The significance of oligoclonal bands in multiple sclerosis: Relevance of demographic and clinical features, and immunogenetic backgrounds

Journal of Neuroimmunology

Volumn 212, Issue 1-2, 2009, Pages 121-124

  Idiman, Egemen ^a   Ozakbas, Serkan ^a   Dogan, Yavuz ^a   Kosehasanogullari, Gorkem ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

EDSS; Human leukocyte antigen; Multiple sclerosis; Oligoclonal band; Prognosis

Indexed keywords

AZATHIOPRINE; HLA DR15 ANTIGEN; IMMUNOGLOBULIN G; OLIGOCLONAL BAND;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; GENE FREQUENCY; GENETIC CORRELATION; HUMAN; IMMUNOGENETICS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; SEX RATIO; TURKEY (REPUBLIC);

ADULT; DISABILITY EVALUATION; FEMALE; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OLIGOCLONAL BANDS; PROGNOSIS;

EID: 67649884741     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.04.014     Document Type: Article

References (23)

1. Andersson M., Alvarez-Cermeño J., Bernardi G., Cogato I., Fredman P., Frederiksen J., Fredrikson S., Gallo P., Grimaldi L.M., and Grønning M. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J. Neurol. Neurosurg. Psychiatry 57 (2006) 897-902
2. Donmez B., Ozakbas S., Oktem M.A., Gedizlioglu M., Coker I., Genc A., and Idiman E. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features. Hum. Immunol. 65 (2004) 752-757
3. Fukazawa T., Moriwaka F., Sugiyama K., Hamada T., and Tashiro K. Cerebrospinal fluid IgG profiles and multiple sclerosis in Japan. Acta Neurol. Scand. 88 (1993) 178-183
4. Fukazawa T., Tashiro K., Hamada T., Moriwaka F., Matsumoto A., Shima K., and Maruo Y. Multiple sclerosis in Hokkaido, the northernmost island of Japan: prospective analyses of clinical features. Int. Med. 31 (1993) 349-352
5. Imrell K., Landtblom A.M., Hillert J., and Masterman T. Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct. Neurology 67 (2006) 1062-1064
6. Kikuchi S., Fukazawa T., Niino M., Yabe I., Miyagishi R., Hamada T., Hashimoto S.A., and Tashiro K. HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands. Neurology 60 (2003) 647-651
7. Kira J., Kanai T., Nishimura Y., Yamasaki K., Matsushita S., Kawano Y., Hasuo K., Tobimatsu S., and Kobayashi T. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann. Neurol. 40 (1996) 569-574
8. Kurtzke J.F. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 (1983) 1444-1552
9. Link H. Comparison of electrophoresis on agar gel and agarose gel in the evaluation of gamma globulin abnormalities in cerebrospinal fluid and serum in multiple sclerosis. Clin. Chim. Acta 46 (1973) 383-389
10. Link H., and Huang Y.M. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. J. Neuroimmunol. 180 (2006) 17-28
11. Lunding J., Midgrad R., and Vedeler C.A. Oligoclonal bands in cerebrospinal fluid: a comparative study of isoelectric focusing, agarose gel electrophoresis and IgG index. Acta Neurol. Scand. 102 (2000) 322-325
12. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F., McFarland H.F., Paty D.W., Polman C.H., Reingold S.C., Sandberg-Wollheim M., Sibley W., Thompson A., van der Nort S., Weinshenker B.Y., and Wolinsky J.S. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann. Neurol. 50 (2001) 121-127
13. McLean B.N., Luxton R.W., and Thompson E.J. A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological diseases using isoelectric focusing and the log-IgG index. Brain 113 (1990) 1269-1289
14. Miller J.R., Burke A., and Bever C.T. Occurrence of oligoclonal bands in multiple sclerosis and other CNS diseases. Ann. Neurol. 13 (1983) 53-58
15. Nakashima I., Fujihara K., Misu T., Fujimori J., Sato S., Takase S., and Itoyamai Y.A. comparative study of Japanese multiple sclerosis patients with and without oligoclonal IgG bands. Mult. Scler. 8 (2002) 459-462
16. Nakashima I., Fujihara K., Miyazawa I., Misu T., Narikawa K., Nakamura M., Watanabe S., Takahashi T., Nishiyama S., Shiga Y., Sato S., Weinshenker B.G., and Itoyama Y. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J. Neurol. Neurosurg. Psychiatry 77 (2006) 1001-1002
17. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., and Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13 (1983) 227-231
18. Ozakbas S., Cagiran I., Ormeci B., and Idiman E. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis. J. Neurol. Sci. 208 (2004) 3-7
19. Ozakbas S., Ormeci B., and Idiman E. Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies. J. Neurol. Sci. 232 (2005) 65-69
20. Sa M.J., Sequeira L., Rio M.E., and Thompson E.J. Oligoclonal IgG bands in the CSF of Portuguese patients with MS. Arq. Neuro-psiquiatry 63 (2005) 375-379
21. Tourtellotte W.W. The cerebrospinal fluid in multiple sclerosis. In: Bruyn G. (Ed). Handbook of Clinical Neurology, Demyelinating Diseases vol. 3 (1988), Elsevier, Amsterdam 79-1302
22. Zeman A.Z., Keir G., Luxton R., and Thompson E.J. Serum oligoclonal IgG is a common and persistent finding in multiple sclerosis, and has a systemic source. QJM 89 (1996) 187-193
23. Zeman A.Z., Kidd D., McLean B.N., Kelly M.A., Francis D.A., Miller D.H., Kendall B.E., Rudge P., Thompson E.J., and McDonald W.I. A study of oligoclonal band negative multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 60 (1996) 27-30